REPL CIK: 1737953

Replimune Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26

Assets

(positive)
Change from FY22 to FY26
billions USD
FY22:
0.40
FY23:
0.59
FY24:
0.43
FY25:
0.50
FY26:
0.28
(positive)
Change from FY22 to FY26
billions USD
FY22:
0.06
FY23:
0.05
FY24:
0.05
FY25:
0.06
FY26:
0.05
Total assets
Change from FY22 to FY26
billions USD
FY22:
0.46
FY23:
0.65
FY24:
0.49
FY25:
0.55
FY26:
0.33

Liabilities & Equity

(negative)
Change from FY22 to FY26
billions USD
FY22:
0.02
FY23:
0.03
FY24:
0.04
FY25:
0.06
FY26:
0.06
(negative)
Change from FY22 to FY26
billions USD
FY22:
0.03
FY23:
0.06
FY24:
0.07
FY25:
0.07
FY26:
0.11
(positive)
Change from FY22 to FY26
billions USD
FY22:
0.41
FY23:
0.56
FY24:
0.37
FY25:
0.42
FY26:
0.17
Total liabilities & equity
Change from FY22 to FY26
billions USD
FY22:
0.46
FY23:
0.65
FY24:
0.49
FY25:
0.55
FY26:
0.33

All amounts in billions USD Data source:SEC EDGAR